Safety Notices

From time to time notices relating to the safety, efficacy and quality of human medicinal products are published by the Health Products Regulatory Authority.

The issues covered by these notices include medicinal product safety information, updated efficacy information on the appropriate usage of medicines and quality defect information.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General information provided by 3rd parties as approved by the HPRA, e.g. MIMS, Direct Healthcare Professional Letter or Product Information Update

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
05/10/2022 Medicinal Product Shortages - update - 5 October 2022 Advisory
30/09/2022 Pharmacovigilance Risk Assessment Committee (PRAC) Meeting Highlights 3rd Party Publications
28/09/2022 Medicinal Product Shortages - update - 28 September 2022 Advisory
21/09/2022 Medicinal Product Shortages - update - 21 September 2022 Advisory
19/09/2022 Product Information Update – Chloromycetin Redidrops Eye Drops (Chloramphenicol) 3rd Party Publications
15/09/2022 HPRA IMF Article September 2022 3rd Party Publications
14/09/2022 Medicinal Product Shortages - update - 14 September 2022 Advisory
08/09/2022 Medicinal Product Shortages - update - 8 September 2022 Advisory
31/08/2022 Medicinal Product Shortages - update - 31 August 2022 Advisory
24/08/2022 Medicinal Product Shortages - update - 24 August 2022 Advisory